251 related articles for article (PubMed ID: 23615343)
1. Intraocular methotrexate can induce extended remission in some patients in noninfectious uveitis.
Taylor SR; Banker A; Schlaen A; Couto C; Matthe E; Joshi L; Menezo V; Nguyen E; Tomkins-Netzer O; Bar A; Morarji J; McCluskey P; Lightman S
Retina; 2013; 33(10):2149-54. PubMed ID: 23615343
[TBL] [Abstract][Full Text] [Related]
2. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
[TBL] [Abstract][Full Text] [Related]
3. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
4. The role of methotrexate in resolving ocular inflammation after specific therapy for presumed latent syphilitic uveitis and presumed tuberculosis-related uveitis.
Sahin O; Ziaei A
Retina; 2014 Jul; 34(7):1451-9. PubMed ID: 24531737
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
Kong X; Psaras C; Stewart JM
Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
[TBL] [Abstract][Full Text] [Related]
7. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
Khurana RN; Porco TC
Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema.
Habot-Wilner Z; Sallam A; Pacheco PA; Do HH; McCluskey P; Lightman S
Eur J Ophthalmol; 2011; 21 Suppl 6():S56-61. PubMed ID: 23264330
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema.
Habot-Wilner Z; Sorkin N; Goldenberg D; Loewenstein A; Goldstein M
Ophthalmologica; 2014; 232(2):77-82. PubMed ID: 25012541
[TBL] [Abstract][Full Text] [Related]
10. Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.
Fabiani C; Vitale A; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Favale RA; Fusco F; Franceschini R; Frediani B; Iannone F; Galeazzi M; Tosi GM; Cantarini L
J Ocul Pharmacol Ther; 2017 Sep; 33(7):549-555. PubMed ID: 28557602
[TBL] [Abstract][Full Text] [Related]
11. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
Vegas-Revenga N; Calvo-Río V; Mesquida M; Adán A; Hernández MV; Beltrán E; Valls Pascual E; Díaz-Valle D; Díaz-Cordovés G; Hernandez-Garfella M; Martínez-Costa L; Calvo I; Atanes A; Linares LF; Modesto C; González-Vela C; Demetrio-Pablo R; Aurrecoechea E; Cordero M; Domínguez-Casas LC; Atienza-Mateo B; Martín-Varillas JL; Loricera J; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
Am J Ophthalmol; 2019 Apr; 200():85-94. PubMed ID: 30660771
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
[TBL] [Abstract][Full Text] [Related]
13. Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis.
Leder HA; Jabs DA; Galor A; Dunn JP; Thorne JE
Am J Ophthalmol; 2011 Sep; 152(3):441-448.e2. PubMed ID: 21652023
[TBL] [Abstract][Full Text] [Related]
14. Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema.
Acharya NR; Sittivarakul W; Qian Y; Hong KC; Lee SM
Retina; 2011 Oct; 31(9):1871-6. PubMed ID: 21716165
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone Inserts in Noninfectious Uveitis: A Single-Center Experience.
Pohlmann D; Vom Brocke GA; Winterhalter S; Steurer T; Thees S; Pleyer U
Ophthalmology; 2018 Jul; 125(7):1088-1099. PubMed ID: 29459041
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Intravitreal Dexamethasone Implant for Refractory Uveitic Macular Edema in Adults and Children.
Ratra D; Barh A; Banerjee M; Ratra V; Biswas J
Ocul Immunol Inflamm; 2018; 26(7):1034-1040. PubMed ID: 29394119
[TBL] [Abstract][Full Text] [Related]
17. [Intravitreal methotrexate for treatment of uveitic cystoid macular edema].
Maaß J; Matthé E
Ophthalmologe; 2018 Jul; 115(7):595-597. PubMed ID: 28755068
[TBL] [Abstract][Full Text] [Related]
18. Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema.
Lasave AF; Zeballos DG; El-Haig WM; Díaz-Llopis M; Salom D; Arevalo JF
Ocul Immunol Inflamm; 2009; 17(6):423-30. PubMed ID: 20001264
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up.
Cervantes-Castañeda RA; Giuliari GP; Gallagher MJ; Yilmaz T; MacDonell RE; Quinones K; Foster CS
Eur J Ophthalmol; 2009; 19(4):622-9. PubMed ID: 19551679
[TBL] [Abstract][Full Text] [Related]
20. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
Bernard Y; Bonnin N; Farguette F; Chiambaretta F
J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
